Literature DB >> 1743698

Rhabdomyolysis associated with cocaine abuse.

K B Nolte1.   

Abstract

There have been recent reports of rhabdomyolysis associated with cocaine abuse. The pathologic findings from these cases have not been described. Pathologic abnormalities in two fatalities with cocaine-associated rhabdomyolysis, including one with hyperpyrexia, acute renal failure, and disseminated intravascular coagulation, are discussed in detail. Skeletal muscle in both cases showed necrosis without evidence of vasculitis, polarizable foreign crystals, or other specific lesions. The individual with renal failure showed acute tubular necrosis with granular myoglobin casts in tubules. The mechanism of cocaine-associated rhabdomyolysis is unclear, but potentially includes ischemia due to vasoconstriction, direct toxicity, hyperpyrexia, and increased muscle activity from agitation or seizure. Adulterants may also play a role. In unexplained cases of rhabdomyolysis, toxicologic evidence of cocaine should be sought. In those cases of rhabdomyolysis associated with acute renal failure, the presence of cocaine in blood may be prolonged because of impaired renal clearance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743698     DOI: 10.1016/0046-8177(91)90267-s

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Multiple mononeuropathy following cocaine abuse.

Authors:  Sándor Beniczky; Peer Tfelt-Hansen; Martin Fabricius; Kjeld V Andersen
Journal:  BMJ Case Rep       Date:  2009-04-28

2.  Confluent muscle pallor: a macroscopic marker of cocaine-induced rhabdomyolysis.

Authors:  Roger W Byard; Glenda Summersides; Amanda Thompson
Journal:  Forensic Sci Med Pathol       Date:  2011-03-06       Impact factor: 2.007

3.  Hyperbaric Oxygen as an Adjunctive Therapy Postfasciotomy for Unilateral Supraspinatus Rhabdomyolysis and Compartment Syndrome.

Authors:  G Hoy; C Hasenkam; A Fock; C McLean
Journal:  Case Rep Orthop       Date:  2018-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.